OMC
OUP Management Company Portfolio holdings
AUM
$44.5M
1-Year Est. Return
54.04%
1 Year Est. Return
+54.04%
AUM
$58.6M
AUM Growth
+$8.53M
(+17%)
Holding
14
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$3.09B
| $18.2M | 31.01% |
2,937,615
|
|
||
|
DICE
2
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $12.5M | 21.26% |
268,346
|
|
||
|
JBIO
3
Jade Biosciences
JBIO
$431M
| $10.4M | 17.66% |
17,250
|
|
||
|
CYT
4
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $6.39M | 10.91% |
2,459,572
|
|
||
5
PMV Pharmaceuticals
PMVP
$74.2M
| $6.19M | 10.56% |
989,232
|
|
||
6
Vor Biopharma
VOR
$199M
| $1.16M | 1.97% |
374,714
|
|
||
|
LENZ
7
LENZ Therapeutics
LENZ
$1.16B
| $1.06M | 1.8% |
58,044
|
|
||
8
Cartesian Therapeutics
RNAC
$234M
| $966K | 1.65% |
28,751
|
|
||
|
EFTR
9
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $852K | 1.45% |
41,028
|
|
||
10
Precision BioSciences
DTIL
$81.3M
| $591K | 1.01% |
37,464
|
|
||
11
Spero Therapeutics
SPRO
$124M
| $361K | 0.62% |
249,070
|
|
||
12
Q32 Bio
QTTB
$38.7M
| $56.6K | 0.1% |
3,556
|
|
||
13
IonQ
IONQ
$21.9B
| – | – |
-389,668
|
|
||
14
Prime Medicine
PRME
$972M
| – | – |
-121,255
|
|